Currently, there are 0.82M common shares owned by the public and among those 0.75M shares have been available to trade.
The company’s stock has a 5-day price change of 29.20% and 41.15% over the past three months. EVOK shares are trading -43.83% year to date (YTD), with the 12-month market performance down to -48.70% lower. It has a 12-month low price of $3.54 and touched a high of $17.88 over the same period. EVOK has an average intraday trading volume of 73.14K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 32.83%, 46.81%, and 13.39% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Evoke Pharma Inc (NASDAQ: EVOK) shares accounts for 35.53% of the company’s 0.82M shares outstanding.
It has a market capitalization of $5.81M and a beta (3y monthly) value of 0.38. The earnings-per-share (ttm) stands at -$16.23. Price movements for the stock have been influenced by the stock’s volatility, which stands at 22.15% over the week and 12.12% over the month.
Earnings per share for the fiscal year are expected to increase by 91.34%, and 109.92% over the next financial year. EPS should grow at an annualized rate of 40.00% over the next five years, compared to 15.68% over the past 5-year period.
Looking at the support for the EVOK, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on June 22, 2020, with the firm’s price target at $10. B. Riley FBR Inc. was of a view on March 08, 2018 that the stock is Buy, while FBR & Co. gave the stock Buy rating on October 19, 2017, issuing a price target of $10. Rodman & Renshaw on their part issued Buy rating on March 16, 2017.
